Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.2M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
1.07M
-
Shares change
-
0
-
Total reported value, excl. options
-
$9.11M
-
Price
-
$8.47
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q4 2023
2 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q4 2023.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.07M shares
of 55.2M outstanding shares and own 1.94% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (4.24M shares), EcoR1 Capital, LLC (3.85M shares), BlackRock Inc. (2.63M shares), VANGUARD GROUP INC (2.53M shares), FARALLON CAPITAL MANAGEMENT LLC (1.29M shares), Erste Asset Management GmbH (1.06M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1M shares), DIMENSIONAL FUND ADVISORS LP (932K shares), GEODE CAPITAL MANAGEMENT, LLC (679K shares), and AQR CAPITAL MANAGEMENT LLC (639K shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.